| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $276K | -45.2% |
| Cost of Revenue | $52K | -72.2% |
| Gross Profit | $224K | -29.3% |
| R&D Expense | $2.0M | -43.5% |
| SG&A Expense | $7.8M | -21.1% |
| Operating Income | -$9.5M | +50.2% |
| Interest Expense | $26K | -50.0% |
| Pre-tax Income | -$8.9M | +51.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $43K | +43.3% |
| Current Assets | $2.4M | +59.6% |
| Total Assets | $9.0M | +7.6% |
| Current Liabilities | $3.4M | -15.7% |
| Total Liabilities | $3.5M | -15.4% |
| Stockholders' Equity | $5.5M | +30.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | +15.8% |
| Investing Cash Flow | -$1.2M | -131.8% |
| Financing Cash Flow | $8.2M | +14.3% |
| — |
| Net Income | -$8.9M | +51.7% |
| EPS (Basic) | -$0.35 | +65.3% |
| EPS (Diluted) | -$0.35 | +65.3% |